推薦產品
運輸包裝
dry ice
儲存溫度
−20°C
一般說明
The Transcreener® UDP2 FP Assay is a universal biochemical HTS assay for enzymes that produce UDP, including glycosyltransferase, galactosyltransferase, glucuronyltransferase, N-acetylglucosamyltransferase, N-acetlygalactosyltransferase, xylosyltransferase, and glycogen, cellulose, lactose and hyaluronan synthases. Enzyme activity is signaled by a decrease in fluorescence polarization as the bound tracer is displaced from the Transcreener® UDP2 Antibody. The assay is a simple single step mix-and-read format enabling the use of unmodified native substrate concentrations of 1 – 1000 μM. The assay provides excellent signal at low substrate conversion, with a Z′ =0.7 and =100 millipolarization shift (mP) under normal reaction conditions.
View full Transcreener® product list
View full Transcreener® product list
數量
3018-1K = 1,000 assay, 384-well
3018-10K = 10,000 assay, 384-well
3018-10K = 10,000 assay, 384-well
外觀
Kit with buffered aqueous solutions
法律資訊
Transcreener is a registered trademark of BellBrook Labs
Traci E Battle et al.
Blood, 102(8), 3016-3024 (2003-07-12)
Bryostatin 1 is known to exhibit in vitro and in vivo activity against chronic lymphocytic leukemia (CLL) cells by inducing their further maturation into plasma-like cells. Signal transducer and activator of transcription (STAT) proteins play a central role in B-lymphocyte
Dennis S Metselaar et al.
EBioMedicine, 50, 81-92 (2019-11-19)
Pediatric high-grade gliomas (pHGG) are the leading cause of cancer-related death during childhood. Due to their diffuse growth characteristics, chemoresistance and location behind the blood-brain barrier (BBB), the prognosis of pHGG has barely improved in the past decades. As such
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務